-
PET Tracking of mRNA Antigen Expression
2026-09-16
This research highlight describes a PET reporter system designed to measure translated mRNA vaccine antigen in vivo. An eDHFR tag encoded with the antigen binds the radiotracer trimethoprim, allowing whole-body imaging of antigen expression rather than simply tracking lipid nanoparticles, labeled RNA, or cellular uptake. The supplied text does not identify an ALC-0315 formulation or provide formulation-level delivery data.
-
DOTAP for Nucleic Acid Delivery and Assay Design
2026-09-08
DOTAP provides a practical cationic-lipid platform for transient gene expression, RNA perturbation, and formulation screening. This guide connects formulation choices with controls, troubleshooting, and the immune-metabolic questions raised by recent nano-zoledronate research.
-
EZ Cap™ Cre mRNA: A Functional Delivery Benchmark
2026-08-28
EZ Cap™ Cre mRNA (m1Ψ) can do more than drive transient recombination: it can help researchers dissect mRNA delivery, translation, and functional protein activity. This article connects the reagent’s molecular design with practical assay decisions inspired by emerging extrahepatic delivery platforms.
-
DOTAP: Cationic Lipid for Nucleic Acid Delivery
2026-08-19
1,2-Dioleoyl-3-trimethylammonium-propane chloride, also called DOTAP, is a synthetic cationic lipid for DNA, RNA, and antisense oligonucleotide delivery. Its electrostatic complexation and formulation flexibility support transient gene expression, functional genomics, and lipid nanoparticle optimization, but performance remains formulation- and cell-type-dependent.
-
1,2-Dioleoyl-3-trimethylammonium-propane Chloride: Optimizin
2026-08-06
1,2-Dioleoyl-3-trimethylammonium-propane chloride (DOTAP) stands out for its versatility in transient and stable gene expression workflows, offering robust performance in both functional genomics and immunometabolic modulation. This article details actionable protocol enhancements, troubleshooting strategies, and cross-disciplinary applications that leverage DOTAP's unique properties for next-generation gene delivery.
-
Intravesical p21 mRNA–LNP Therapy: Advancing Bladder Cancer
2026-08-06
This study establishes a novel approach for bladder cancer therapy by delivering p21 mRNA via lipid nanoparticles (LNPs) directly into the bladder. The method restores tumor suppressor function, achieving robust local protein expression and significant tumor inhibition with minimal systemic effects.
-
1,2-Dioleoyl-3-trimethylammonium-propane Chloride in Advance
2026-07-28
DOTAP’s cationic lipid architecture enables reproducibly high gene transfer efficiency in both transient and stable expression workflows, even in challenging primary cells. Recent innovations, including its role in targeted ocular nanoparticle delivery, illustrate how DOTAP empowers next-generation functional genomics and disease modeling.
-
OMV-Mediated mRNA Display for Rapid Personalized Tumor Vacci
2026-07-19
Li et al. introduce a bacteria-derived outer membrane vesicle (OMV) platform for rapid, surface-displayed mRNA antigen delivery in personalized tumor vaccines. By engineering OMVs to bind and deliver modified mRNA, this system overcomes key limitations of lipid nanoparticle-based mRNA vaccines, demonstrating robust antitumor immunity and long-term protection in murine models.
-
1,2-Dioleoyl-3-trimethylammonium-propane Chloride in Gene De
2026-07-05
1,2-Dioleoyl-3-trimethylammonium-propane chloride (DOTAP) unlocks reliable and efficient nucleic acid delivery for both transient and stable gene expression. Explore experimental protocols, practical troubleshooting, and cutting-edge applications, including immunometabolic nanoparticle engineering, that set APExBIO's DOTAP apart for advanced biomedical workflows.
-
Optimizing Storage of LNP-Formulated Self-Replicating RNA Va
2026-06-20
This study systematically evaluates how storage conditions affect the stability and bioactivity of lipid nanoparticle (LNP)-formulated self-replicating RNA vaccines. The findings define practical parameters for maintaining vaccine potency, with implications for mRNA delivery research and translational workflows.
-
Microfluidic Peptide/RNA Complexes for Nebulized Pulmonary D
2026-06-15
This study presents a robust microfluidic approach to prepare peptide-based mRNA and siRNA complexes optimized for nebulized pulmonary delivery. The work demonstrates that both LAH4-L1 and PEG12KL4 peptide vectors maintain transfection efficiency and structural integrity after aerosolization, underscoring their promise for clinical translation in treating lung diseases.
-
GPC3-HSP70 mRNA Nanovaccine and PD-L1 Blockade in HCC Immuni
2026-05-21
This study presents a novel mRNA nanovaccine encoding glypican-3 CTL epitopes fused with HSP70 and demonstrates that its combination with anti-PD-L1 therapy elicits robust T-cell-mediated immunity against hepatocellular carcinoma. The findings highlight advances in rational antigen design, targeted mRNA delivery, and the synergistic potential of combining mRNA vaccination with immune checkpoint blockade.
-
Cholesterol Impedes Lipid Nanoparticle Intracellular Traffic
2026-05-11
This study reveals that elevated cholesterol within lipid nanoparticles (LNPs) hinders intracellular trafficking by promoting peripheral endosome aggregation, thereby reducing cargo delivery efficiency. The findings refine our understanding of LNP composition optimization for effective nucleic acid delivery.
-
EZ Cap Cy5 Firefly Luciferase mRNA: Next-Gen mRNA Trackin...
2025-12-11
Explore the scientific foundation and advanced applications of EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP), a 5-moUTP modified mRNA enabling dual fluorescence and bioluminescence detection with suppressed innate immune activation. Discover how this Cap1 capped, Cy5-labeled mRNA redefines mRNA delivery, tracking, and translational research beyond current paradigms.
-
EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP): Dual-Mode, ...
2025-12-10
EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) provides a Cap1-capped, 5-moUTP-modified, and Cy5-labeled mRNA for high-fidelity mammalian expression. This product enables quantitative bioluminescence and real-time fluorescent tracking, supporting enhanced translation efficiency and suppressed innate immune activation. Its dual-mode detection and engineered stability offer robust performance for mRNA delivery, reporter gene assays, and in vivo imaging.